GUARDIN is a p53-responsive long non-coding RNA that is essential for genomic stability

被引:239
作者
Hu, Wang Lai [1 ,2 ,3 ]
Jin, Lei [4 ]
Xu, An [1 ]
Wang, Yu Fang [5 ]
Thorne, Rick F. [2 ,6 ]
Zhang, Xu Dong [2 ,4 ]
Wu, Mian [1 ,2 ]
机构
[1] Univ Sci & Technol China, CAS Ctr Excellence Cell & Mol Biol, Innovat Ctr Cell Signalling Network,Sch Life Sci, Chinese Acad Sci CAS,Key Lab Innate Immun & Chron, Hefei, Peoples R China
[2] Henan Prov Peoples Hosp, Translat Res Inst, Zhengzhou, Henan, Peoples R China
[3] Anhui Med Univ, Dept Immunol, Hefei, Anhui, Peoples R China
[4] Univ Newcastle, Sch Med & Publ Hlth, Callaghan, NSW, Australia
[5] Sichuan Univ, Sch Preclin & Forens Med, Dept Pathophysiol, Chengdu, Sichuan, Peoples R China
[6] Univ Newcastle, Sch Environm & Life Sci, Newcastle, NSW, Australia
基金
国家重点研发计划; 中国国家自然科学基金;
关键词
ONCOGENE-INDUCED SENESCENCE; DNA-DAMAGE; HOMOLOGOUS RECOMBINATION; BREAST-CANCER; CELLULAR SENESCENCE; TUMOR SUPPRESSION; REPAIR PATHWAY; HUMAN-MELANOMA; P53; FAMILY; IN-VIVO;
D O I
10.1038/s41556-018-0066-7
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The list of long non-coding RNAs (lncRNAs) involved in the p53 pathway of the DNA damage response is rapidly expanding, but whether lncRNAs have a role in maintaining the de novo structure of DNA is unknown. Here, we demonstrate that the p53-responsive lncRNA GUARDIN is important for maintaining genomic integrity under steady-state conditions and after exposure to exogenous genotoxic stress. GUARDIN is necessary for preventing chromosome end-to-end fusion through maintaining the expression of telomeric repeat-binding factor 2 (TRF2) by sequestering microRNA-23a. Moreover, GUARDIN also sustains breast cancer 1 (BRCA1) stability by acting as an RNA scaffold to facilitate the heterodimerization of BRCA1 and BRCA1-associated RING domain protein 1 (BARD1). As such, GUARDIN silencing triggered apoptosis and senescence, enhanced cytotoxicity of additional genotoxic stress and inhibited cancer xenograft growth. Thus, GUARDIN may constitute a target for cancer treatment.
引用
收藏
页码:492 / +
页数:13
相关论文
共 69 条
[61]   Cancer-derived p53 mutants suppress p53-target gene expression - potential mechanism for gain of function of mutant p53 [J].
Vikhanskaya, Faina ;
Lee, Ming Kei ;
Mazzoletti, Marco ;
Broggini, Massimo ;
Sabapathy, Kanaga .
NUCLEIC ACIDS RESEARCH, 2007, 35 (06) :2093-2104
[62]   Surfing the p53 network [J].
Vogelstein, B ;
Lane, D ;
Levine, AJ .
NATURE, 2000, 408 (6810) :307-310
[63]   Mutant p53-R273H gains new function in sustained activation of EGFR signaling via suppressing miR-27a expression [J].
Wang, W. ;
Cheng, B. ;
Miao, L. ;
Mei, Y. ;
Wu, M. .
CELL DEATH & DISEASE, 2013, 4 :e574-e574
[64]  
Wang Y, 2000, GENE DEV, V14, P927
[65]  
WynfordThomas D, 1996, J PATHOL, V180, P118, DOI 10.1002/(SICI)1096-9896(199610)180:2<118::AID-PATH673>3.0.CO
[66]  
2-I
[67]   The telosome/shelterin complex and its functions [J].
Xin, Huawei ;
Liu, Dan ;
Zhou Songyang .
GENOME BIOLOGY, 2008, 9 (09) :232
[68]   MicroRNA-23a downregulates the expression of interferon regulatory factor-1 in hepatocellular carcinoma cells [J].
Yan, Yihe ;
Liang, Zhihai ;
Du, Qiang ;
Yang, Muqing ;
Geller, David A. .
ONCOLOGY REPORTS, 2016, 36 (02) :633-640
[69]   miR-34a functions as a tumor suppressor modulating EGFR in glioblastoma multiforme [J].
Yin, D. ;
Ogawa, S. ;
Kawamata, N. ;
Leiter, A. ;
Ham, M. ;
Li, D. ;
Doans, N. B. ;
Said, J. W. ;
Black, K. L. ;
Koeffler, H. Phillip .
ONCOGENE, 2013, 32 (09) :1155-1163